The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins
Open accessAbstract
A number of proteins have been rendered functionally oestrogen-dependent by fusion with the hormone-binding domain of the oestrogen receptor. There are, however, several significant disadvantages with such fusion proteins. First, their use in cells in vitro requires phenol red-free medium and laborious stripping of steroid hormones from serum in order to avoid constitutive activation. Secondly, control of oestrogen receptor fusion proteins in vivo is precluded by high endogenous levels of circulating oestrogens. Thirdly, the hormone-binding domain of the oestrogen receptor functions as a hormone-dependent transcriptional activation domain making interpretation of fusions with transcription factors problematical. In order to overcome these drawbacks we have used a transcriptionally inactive mutant of the murine oestrogen receptor which is unable to bind oestrogen yet retains normal affinity for the synthetic ligand, 4-hydroxytamoxifen. When the hormone-binding domain of this mutant oestrogen receptor is fused to the C-terminus of the c-Myc protein, Myc-induced proliferation and apoptosis in fibroblasts becomes dependent on 4-hydroxytamoxifen, but remains refractory to 17 beta-oestradiol.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Induction of apoptosis in fibroblasts by c-myc protein
Evan, G. I., Wyllie, A. H., Gilbert, C. S., Littlewood, T. D., Land, H., Brooks, M., Waters, C. M., Penn, L. Z., & Hancock, D. C. (1992) · Cell · doi:10.1016/0092-8674(92)90123-t · Cited by 2,935
Self-citationMorgenstern, J. P., & Land, H. (1990) · Nucleic Acids Research · doi:10.1093/nar/18.12.3587 · Cited by 2,101
Berthois, Y., Katzenellenbogen, J. A., & Katzenellenbogen, B. S. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.8.2496 · Cited by 1,307
The human estrogen receptor has two independent nonacidic transcriptional activation functions
Tora, L., White, J., Brou, C., Tasset, D., Webster, N., Scheer, E., & Chambon, P. (1989) · Cell · doi:10.1016/0092-8674(89)90031-7 · Cited by 1,048
Isolation of Monoclonal Antibodies Specific for Human c-myc Proto-Oncogene Product
Evan, G. I., Lewis, G. K., Ramsay, G., & Bishop, J. M. (1985) · Molecular and Cellular Biology · doi:10.1128/mcb.5.12.3610-3616.1985 · Cited by 794
Self-citationBerry, M., Metzger, D., & Chambon, P. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07469.x · Cited by 767
Cooperative interaction between c-myc and bcl-2 proto-oncogenes
Fanidi, A., Harrington, E. A., & Evan, G. I. (1992) · Nature · doi:10.1038/359554a0 · Cited by 759
Self-citationc-Myc-induced apoptosis in fibroblasts is inhibited by specific cytokines.
Harrington, E. A., Bennett, M. R., Fanidi, A., & Evan, G. I. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06630.x · Cited by 742
Self-citationCCAAT-Enhancer Binding Protein: A Component of a Differentiation Switch
Umek, R. M., Friedman, A. D., & McKnight, S. L. (1991) · Science · doi:10.1126/science.1987644 · Cited by 712
WEBSTER, N. (1988) · Cell · doi:10.1016/0092-8674(88)90552-1 · Cited by 580
Cited by
Items 101–133 of 133
Pollock, K., Stroemer, P., Patel, S., Stevanato, L., Hope, A., Miljan, E., Dong, Z., Hodges, H., Price, J., & Sinden, J. D. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2005.12.011 · Cited by 277
MYC Disrupts the Circadian Clock and Metabolism in Cancer Cells
Altman, B. J., Hsieh, A. L., Sengupta, A., Krishnanaiah, S. Y., Stine, Z. E., Walton, Z. E., Gouw, A. M., Venkataraman, A., Li, B., Goraksha-Hicks, P., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.09.003 · Cited by 274
Glading, A., Bodnar, R. J., Reynolds, I. J., Shiraha, H., Satish, L., Potter, D. A., Blair, H. C., & Wells, A. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.6.2499-2512.2004 · Cited by 271
Maclean, K. H., Dorsey, F. C., Cleveland, J. L., & Kastan, M. B. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33700 · Cited by 272
(2001) · PubMed · Cited by 270
Leone, D. P., Genoud, S. T., Atanasoski, S., Grausenburger, R., Berger, P., Metzger, D., Macklin, W. B., Chambon, P., & Suter, U. (2003) · Molecular and Cellular Neuroscience · doi:10.1016/s1044-7431(03)00029-0 · Cited by 270
MYCN regulates oncogenic MicroRNAs in neuroblastoma
Schulte, J. H., Horn, S., Otto, T., Samans, B., Heukamp, L. C., Eilers, U., Krause, M., Astrahantseff, K., Klein‐Hitpass, L., Buettner, R., et al. (2008) · International Journal of Cancer · doi:10.1002/ijc.23153 · Cited by 267
Van Mater, D., Kolligs, F. T., Dlugosz, A. A., & Fearon, E. R. (2003) · Genes & Development · doi:10.1101/gad.1076103 · Cited by 263
“…polypeptide sequences of interest fused to the hormonebinding domain of the mouse ER protein has been a successful strategy for exploring protein function, because the activity of the ER fusion protein can be tightly regulated by 4-OHT, an estrogen agonist/antagonist (Littlewood et al. 1995).”
BackgroundMethodKlippel, A., Escobedo, M.-A., Wachowicz, M. S., Apell, G., Brown, T. W., Giedlin, M. A., Kavanaugh, W. M., & Williams, L. T. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.10.5699 · Cited by 258
O’Connor, R., Kauffmann-Zeh, A., Liu, Y., Lehar, S., Evan, G. I., Baserga, R., & Blättler, W. A. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.1.427 · Cited by 255
Self-citationc-Myc and eIF4F Are Components of a Feedforward Loop that Links Transcription and Translation
Lin, C.-J., Cencic, R., Mills, J. R., Robert, F., & Pelletier, J. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5876 · Cited by 180
Cre‐lox P‐Mediated Recombination: General Principles and Experimental Considerations
McLellan, M. A., Rosenthal, N. A., & Pinto, A. R. (2017) · Current Protocols in Mouse Biology · doi:10.1002/cpmo.22 · Cited by 172
Wang, X., Scott, E., Sawyers, C. L., & Friedman, A. D. (1999) · Blood · doi:10.1182/blood.v94.2.560 · Cited by 166
MYC in mammalian epidermis: how can an oncogene stimulate differentiation?
Watt, F. M., Frye, M., & Benitah, S. A. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2328 · Cited by 157
“In cells expressing MYC–ER, MYC is only active when cells are exposed to 4-hydroxy-tamoxifen (4-OHT”
Yu, Y., Schleich, K., Yue, B., Ji, S., Lohneis, P., Kemper, K., Silvis, M. R., Qutob, N., van Rooijen, E., Werner-Klein, M., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.01.002 · Cited by 156
Muller, A. J., Baker, J. F., DuHadaway, J. B., Ge, K., Farmer, G., Donover, P. S., Meade, R., Reid, C., Grzanna, R., Roach, A. H., et al. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.12.4295-4306.2003 · Cited by 139
“Evan [33]) or empty vector the”
Luminal iron levels govern intestinal tumorigenesis after Apc loss in vivo
Radulescu, S., Brookes, M. J., Salgueiro, P., Ridgway, R. A., McGhee, E., Anderson, K., Ford, S. J., Stones, D. H., Iqbal, T. H., Tselepis, C., et al. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.07.003 · Cited by 130
“…iron regulatory protein 2 (IRP2) and ferritin, we overexpressed c-MYC in the RKO cell line using the well-characterized c-MycER system (Figure 2; Littlewood et al., 1995; O’Donnell et al., 2006; Wu et al., 1999). c-MYC induction mediated by tamoxifen treatment resulted in increased mRNA of TfR1…”
MethodMdm2 haplo‐insufficiency profoundly inhibits Myc‐induced lymphomagenesis
Alt, J. R., Greiner, T. C., Cleveland, J. L., & Eischen, C. M. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg133 · Cited by 129
Site-Specific Recombinases for Manipulation of the Mouse Genome
Birling, M.-C., Gofflot, F., & Warot, X. (2009) · Methods in Molecular Biology · doi:10.1007/978-1-60327-019-9_16 · Cited by 106
Eilers, A., Whitfield, J., Shah, B., Spadoni, C., Desmond, H., & Ham, J. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00150.x · Cited by 96
The structure of the Klf4 DNA-binding domain links to self-renewal and macrophage differentiation
Schuetz, A., Nana, D., Rose, C., Zocher, G., Milanovic, M., Koenigsmann, J., Blasig, R., Heinemann, U., & Carstanjen, D. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0618-x · Cited by 84
c-MYC-Induced Sebaceous Gland Differentiation Is Controlled by an Androgen Receptor/p53 Axis
Cottle, D. L., Kretzschmar, K., Schweiger, P. J., Quist, S. R., Gollnick, H. P., Natsuga, K., Aoyagi, S., & Watt, F. M. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.01.013 · Cited by 80
Practical Use of Immortalized Cells in Medicine: Current Advances and Future Perspectives
Voloshin, N., Tyurin-Kuzmin, P., Karagyaur, M., Akopyan, Z., & Kulebyakin, K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241612716 · Cited by 77
Drug Inducible CRISPR/Cas Systems
Zhang, J., Chen, L., Zhang, J., & Wang, Y. (2019) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2019.07.015 · Cited by 69
c-Myc induces changes in higher order rDNA structure on stimulation of quiescent cells
Shiue, C.-N., Berkson, R. G., & Wright, A. P. H. (2009) · Oncogene · doi:10.1038/onc.2009.21 · Cited by 69
Albajar, M., Gómez-Casares, M. T., Llorca, J., Mauleon, I., Vaqué, J. P., Acosta, J. C., Bermúdez, A., Donato, N., Delgado, M. D., & León, J. (2011) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-10-0356 · Cited by 62
Disabled-2 is transcriptionally regulated by ICSBP and augments macrophage spreading and adhesion
Rosenbauer, F., Kallies, A., Scheller, M., Knobeloch, K., Rock, C. O., Schwieger, M., Stocking, C., & Horak, I. (2002) · The EMBO Journal · doi:10.1093/emboj/21.3.211 · Cited by 59
Design of Conditionally Active STATs: Insights into STAT Activation and Gene Regulatory Function
Milocco, L. H., Haslam, J. A., Rosen, J., & Seidel, H. M. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.4.2913 · Cited by 52
Liu, L., & Eisenman, R. N. (2012) · Genes & Cancer · doi:10.1177/1947601912448067 · Cited by 47
“S2).(42,43) Under these conditions, we again observe decreased GSK3β S9 phosphorylation upon 4-OHT treatment.”
BackgroundCell Immortalization: In Vivo Molecular Bases and In Vitro Techniques for Obtention
de Bardet, J. C., Cardentey, C. R., González, B. L., Patrone, D., Mulet, I. L., Siniscalco, D., & Robinson-Agramonte, M. D. L. A. (2023) · BioTech · doi:10.3390/biotech12010014 · Cited by 35
“The c-Myc ERTAM conditional immortalization tool uses the fusion gene encoding a chimeric protein formed by c-myc, and an N-terminal truncated hormonal binding domain of the G525 mutant murine estrogen receptor that cannot bind 17β-estradiol and estrogen but responds to activation with4-hydroxy tamoxifen (4-OHT), a sy…”
MethodBull, J. J., Pelengaris, S., Hendrix, S., Chronnell, C. M. T., Khan, M., & Philpott, M. P. (2005) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2005.06458.x · Cited by 32
King, L. E., Rodriguez-Enriquez, R., Pedley, R., Mellor, C. E. L., Wang, P., Zindy, E., White, M. R. H., Brennan, K., & Gilmore, A. P. (2022) · Cell Death & Differentiation · doi:10.1038/s41418-022-01013-z · Cited by 26
Radziszewska, A., Schroer, S. A., Choi, D., Tajmir, P., Radulovich, N., Ho, J. C., Wang, L., Liadis, N., Hakem, R., Tsao, M.-S., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m806960200 · Cited by 22
Self-citation
Metadata
- Authors
- Littlewood, T. D., Hancock, D. C., Danielian, P. S., Parker, M. G., & Evan, G. I.
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 1995-05-25
- Volume
- 23
- Issue
- 10
- Pages
- 1686-1690
- ISSN
- 0305-1048 (ISSN-L)
- 1362-4962
- OpenAlex
- W2037872087
- Cited by
- 781
- References
- 40
- FWCI
- 11.56
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.